The International Journal of Hyperthermia is an Open Access, peer-reviewed journal publishing research and clinical studies on thermal energy-based disease treatments. It is the official journal of the Society for Thermal Medicine, the European Society for Hyperthermic Oncology, and the Japanese Society for Thermal Medicine.

The journal’s audience includes researchers and clinicians from all backgrounds as the journal publishes research related to the clinical studies, biological studies, and physics/engineering studies of therapeutic thermal therapies.

The journal has a special interest in the following topics:
• Clinical studies describing whole, regional or local treatment in humans or other animals covering the application of therapeutic thermal energy treatment alone or in combination with other clinical modalities
• Clinical outcomes on the physiological effects of heat or cold stress
• Clinical testing of methods related to thermal technologies
• Biological studies incorporating biochemical, anatomical or physiological studies of a basic or preclinical nature using basic biochemical, cell, animal, or computational models
• Research covering thermal tolerance, stress or shock, response and injury, immunological and physiological effects, toxicity and drug delivery, gene therapy, nanotechnology and nanomedicine
• The development of technologies and strategies for energy delivery and control, with an end goal to effect specific biologic responses leading to therapeutic outcomes
• Modalities and technology of therapy delivery, imaging, temperature management, and treatment monitoring and verification
• Advances in energy systems to produce tissue heating or cooling, or temperature monitoring and validation, or to control tissue temperature regulation
• Methods of measuring and modelling hypothermia and the thermal therapies and related technologies and systems

The journal welcomes for consideration the following article types: original articles, reviews, and letters to the editor. All articles received by the Journal will be subject to single-anonymous peer review.